Skip to content

Lumbar Plexus Block for Postoperative Pain Control After Hip Arthroscopy. A Randomized Controlled Trial

Lumbar Plexus Block for Postoperative Pain Control After Hip Arthroscopy. A Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01286805
Acronym
LPB Hip Scope
Enrollment
83
Registered
2011-01-31
Start date
2010-05-31
Completion date
2011-05-31
Last updated
2013-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

The purpose of this study is to determine whether the use of a lumbar plexus block for arthroscopic hip surgery is superior to oral and intravenous opioid pain medications alone in treating pain. In addition, the study will examine whether lumbar plexus blocks reduce the total amount of pain medication needed, and therefore reduce the side effects of these medicines and increase patient satisfaction. It is hypothesized that addition of the lumbar plexus block will significantly reduce patients' postoperative pain.

Interventions

PROCEDURELumbar Plexus Blockade

The lumbar plexus block will be dosed with 30 milliliters of 0.25% bupivacaine with 1:200,000 epinephrine

PROCEDUREControl

The control group will receive only a combined spinal-epidural.

Sponsors

New York Presbyterian Hospital
CollaboratorOTHER
Hospital for Special Surgery, New York
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists (ASA) Class 1-3 * Patients aged 18 to 65 years * Patients scheduled for primary, unilateral arthroscopic hip surgery by Dr. Kelly, Dr. Coleman, or Dr. Anil Ranawat * Planned use of neuraxial anesthesia * Body Mass Index less than 35 * Ability to follow study protocol

Exclusion criteria

* Chronic opioid use (defined as daily or almost daily use of opioids for \>3 months) * Contraindication to combined spinal-epidural anesthesia including but not limited to bleeding disorder, use of clinically relevant anticoagulant or antiplatelet medications, and anatomic abnormalities. * Contraindication to lumbar plexus block including but not limited to bleeding disorder, use of clinically relevant anticoagulant or antiplatelet medications, and anatomic abnormalities. * Infection at the injection site(s) * Allergy to any of the study medications * Contraindication to a short course of NSAIDs (renal failure, intolerance) * ASA Class 4-5 * Patient refusal * Patients younger than 18 years old and older than 65 * Patients with any known indwelling hardware of the lumbar spine. * Patients with a peripheral neuropathy of the surgical extremity * Non-English speaking patients

Design outcomes

Primary

MeasureTime frameDescription
Numeric Rating Scale (NRS) Pain at Rest (0-10) on Day of Surgery Prior to DischargeDay of surgery prior to dischargeThe Numeric Rating Scale was used to ask patients to rate their pain at rest on a scale of 0 to 10, 0 = no pain and 10 = worst pain imaginable.

Secondary

MeasureTime frameDescription
Narcotic Pain Medication NeededDay of surgery prior to discharge
Incidence of NauseaDay of surgery prior to dischargeThe number of participants with nausea.
Incidence of VomitingDay of surgery prior to dischargeThe number of participants who vomited.
Readiness to Discharge From Post-Anesthesia Care Unit (PACU)Day of surgery prior to dischargeTime to readiness for discharge from the PACU. Patients were considered ready for PACU discharge when they met the following criteria: a) Awake, alert, oriented and responsive b) Minimal pain, Numeric Rating Scale \< 5/10 (0 = no pain, 10 = worst imaginable pain) (parenteral \[injected\] medications not required) c) Vital signs stable d) No active bleeding e) Minimal or no nausea f) Not vomiting, tolerating oral intake g) Oxygen saturation \> 94% (or baseline) on room air h) Patient has urinated.
Patient SatisfactionFirst 24 hours after surgeryPatient Satisfaction (0-10; 0 = very dissatisfied, 10 = very satisfied)
Quality of Recovery (QoR-40) Physical Comfort DimensionFirst 24 hours after surgeryAssessment of Physical Comfort (minimum score = 12, maximum score = 60). Higher values represent a better outcome
Requirement of Antiemetic RescueDay of surgery prior to dischargeThe number of participants who needed medication to treat their nausea and vomiting.

Countries

United States

Participant flow

Participants by arm

ArmCount
Lumbar Plexus Blockade + CSE
The study group received a lumbar plexus blockade with 30 mL of 0.25% bupivacaine with 1:200,000 epinephrine, followed by a combined spinal-epidural.
41
Control Group
The control group received only a combined spinal-epidural.
41
Total82

Baseline characteristics

CharacteristicLumbar Plexus Blockade + CSEControl GroupTotal
Age Continuous33 years
STANDARD_DEVIATION 11
37 years
STANDARD_DEVIATION 11
35 years
STANDARD_DEVIATION 11
Sex: Female, Male
Female
21 Participants20 Participants41 Participants
Sex: Female, Male
Male
20 Participants21 Participants41 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 420 / 41
serious
Total, serious adverse events
3 / 422 / 41

Outcome results

Primary

Numeric Rating Scale (NRS) Pain at Rest (0-10) on Day of Surgery Prior to Discharge

The Numeric Rating Scale was used to ask patients to rate their pain at rest on a scale of 0 to 10, 0 = no pain and 10 = worst pain imaginable.

Time frame: Day of surgery prior to discharge

ArmMeasureValue (MEAN)Dispersion
Lumbar Plexus Blockade + CSENumeric Rating Scale (NRS) Pain at Rest (0-10) on Day of Surgery Prior to Discharge3.3 units on a scaleStandard Deviation 2.2
Control GroupNumeric Rating Scale (NRS) Pain at Rest (0-10) on Day of Surgery Prior to Discharge4.2 units on a scaleStandard Deviation 1.8
Secondary

Incidence of Nausea

The number of participants with nausea.

Time frame: Day of surgery prior to discharge

ArmMeasureValue (NUMBER)
Lumbar Plexus Blockade + CSEIncidence of Nausea14 participants
Control GroupIncidence of Nausea8 participants
Secondary

Incidence of Vomiting

The number of participants who vomited.

Time frame: Day of surgery prior to discharge

ArmMeasureValue (NUMBER)
Lumbar Plexus Blockade + CSEIncidence of Vomiting1 participants
Control GroupIncidence of Vomiting3 participants
Secondary

Narcotic Pain Medication Needed

Time frame: Day of surgery prior to discharge

ArmMeasureValue (MEAN)Dispersion
Lumbar Plexus Blockade + CSENarcotic Pain Medication Needed21 equivalents milligrams oral morphineStandard Deviation 17
Control GroupNarcotic Pain Medication Needed29 equivalents milligrams oral morphineStandard Deviation 21
Secondary

Patient Satisfaction

Patient Satisfaction (0-10; 0 = very dissatisfied, 10 = very satisfied)

Time frame: First 24 hours after surgery

ArmMeasureValue (MEAN)Dispersion
Lumbar Plexus Blockade + CSEPatient Satisfaction8.6 units on a scaleStandard Deviation 1.6
Control GroupPatient Satisfaction7.9 units on a scaleStandard Deviation 2.5
Secondary

Quality of Recovery (QoR-40) Physical Comfort Dimension

Assessment of Physical Comfort (minimum score = 12, maximum score = 60). Higher values represent a better outcome

Time frame: First 24 hours after surgery

ArmMeasureValue (MEAN)Dispersion
Lumbar Plexus Blockade + CSEQuality of Recovery (QoR-40) Physical Comfort Dimension53 QoR-40 Physical Comfort scoreStandard Deviation 4.3
Control GroupQuality of Recovery (QoR-40) Physical Comfort Dimension52 QoR-40 Physical Comfort scoreStandard Deviation 7.4
Secondary

Readiness to Discharge From Post-Anesthesia Care Unit (PACU)

Time to readiness for discharge from the PACU. Patients were considered ready for PACU discharge when they met the following criteria: a) Awake, alert, oriented and responsive b) Minimal pain, Numeric Rating Scale \< 5/10 (0 = no pain, 10 = worst imaginable pain) (parenteral \[injected\] medications not required) c) Vital signs stable d) No active bleeding e) Minimal or no nausea f) Not vomiting, tolerating oral intake g) Oxygen saturation \> 94% (or baseline) on room air h) Patient has urinated.

Time frame: Day of surgery prior to discharge

ArmMeasureValue (MEAN)Dispersion
Lumbar Plexus Blockade + CSEReadiness to Discharge From Post-Anesthesia Care Unit (PACU)216 minutesStandard Deviation 86
Control GroupReadiness to Discharge From Post-Anesthesia Care Unit (PACU)187 minutesStandard Deviation 59
Secondary

Requirement of Antiemetic Rescue

The number of participants who needed medication to treat their nausea and vomiting.

Time frame: Day of surgery prior to discharge

ArmMeasureValue (NUMBER)
Lumbar Plexus Blockade + CSERequirement of Antiemetic Rescue5 participants
Control GroupRequirement of Antiemetic Rescue5 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026